The ASP committee updated the COVID guidelines. You will find the following change:
-Removal of the pre-exposure prophylaxis guidelines since monoclonal antibodies are no longer easly available.
-Clarification on the Remdesivir dosing in CKD
-CT value should not guide treatment decision in patient with COVID since it was associated with morbidity in the MUHC.
Thank you!
Francois Bourdeau
Correction made for Heart transplant and Lung transplant recipients: both anti-mold AND anti-PJP prophylaxis recommended.
To MUHC users: Please note that as of Dec 5, 2022, requests for outpatient antiviral management of COVID-19 for HIGH RISK patients should be directed to the ID-AMB (formerly MicroB/Lachine) service ra
The MUHC ASP committee is happy to announce the update and publication of several guidelines: Pre-exposure prophylaxis to COVID : Recommended Evusheld dose is now increased to 300/300 mg COVID managem